Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by Valuehunter72on Jun 11, 2020 9:30am
89 Views
Post# 31137939

RE:RE:RE:RE:RE:----------MAY 5TH $1,400,000 IN THE BANK--

RE:RE:RE:RE:RE:----------MAY 5TH $1,400,000 IN THE BANK--Speculation on my part. The sudden funding requirement happened close to the Strategic Innovation Fund Revealing. A fund where you need to come up with 50% of the capital, and the fund will match it. If they can get free funding to pay for half of phase 1.....why not. Thing is.....they must already know they are heading to phase 1 if they are going for the funding......No announcement of material news to existing shareholders....just dilution for them. Same time I put this together....the other site of bankers and brokers got all pissy with me....hmmmmmm.
<< Previous
Bullboard Posts
Next >>